Keywords: Anterior clinoidal meningioma; Encased vessels; Extradural; Perforators; Surgical technique; ICA; Internal carotid artery; ON; Optic nerve; SOF; Superior orbital fissure;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Anterior clinoid process; Neurosurgery; Optic canal; Paraclinoid space; Skull base; ACP; Anterior clinoid process; CS; cavernous sinus; ICA; internal carotid artery; LSW; lesser sphenoid wing; OC; optic canal; OTPF; orbito-temporal periosteal fold; SOF; s
Keywords: ADL; Activities of Daily Living; FI; Frailty Index; mSOF; modified Study of Osteoporotic Fractures Frailty Index; PHS; Physicians' Health Study; PHS FI; Physicians' Health Study Frailty Index; SOF; Study of Osteoporotic Fractures; Frailty; Frailty Ind
Keywords: Endonasal approach; Endoscopy; Parasellar region; Transmaxillary approach; cICA; Cavernous segment of the internal carotid artery; OCR; Opticocarotid recess; SOF; Superior orbital fissure;
Keywords: Fractionated radiation; Gross total resection; Spheno-orbital meningioma; Tumor recurrence; CSF; Cerebrospinal fluid; EI; Exophthalmos index; GTR; Gross total resection; SOF; Superior orbital fissure; SOM; Spheno-orbital meningioma; SRS; Fractionated ster
Keywords: ABC; ATP-binding cassette; BCRP; breast cancer resistance protein; BEA; beauvericin; COC; cumulus oocyte complex; DAPI; 4,6-diamino-2-phenyl-indole; EFSA; European Food Safety Authority; EtHD-1; ethidium homodimer-1; IVM; in vitro maturation; M2; metaphas
Keywords: Brainstem; Cavernous sinus; Cerebral angiography; Chopstick; ICA occlusion; Orbital apex syndrome; Transorbital penetrating injury; CN; Cranial nerve; CSF; Cerebrospinal fluid; CT; Computed tomography; FB; Foreign body; GCS; Glasgow Coma Scale; ICA; Inter
Keywords: Aging; Insomnia; Prospective research; Risk factors; Sleep disturbance; Sleep quality; ADL; activity of daily living; DIS; difficulty initiating sleep; DMS; difficulty maintaining sleep; EMA; early morning awakening; MrOS; osteoporotic fractures in men st
Keywords: A/F; air to fuel ratio; ASTM; American Society for Testing and Materials; BMEP; Brake Mean Effective Pressure; BSCO; brake specific CO; BSFC; brake specific fuel consumption; BSHC; brake specific HC; BSNOx; brake specific NOx; BTDC; Before Top Dead Center
Keywords: Llama; Pregnancy; IVF; IVC; SOF; Embryo transfer
Keywords: RME; SOF; Redox activity; Unregulated emissions; n-Alkanes;
Keywords: BOEC; bovine oviduct epithelial cells; DEG; differentially expressed genes; IVP; in vitro production; IVF; in vitro fertilization; IFNT; interferon tau; COC; cumulus-oocyte complexes; FCS; foetal calf serum; SOF; synthetic oviductal fluid; TCM-199; tissue
Keywords: Battery monitoring; On-line estimation algorithm; Power prediction; State of charge; State of health; AEKF; adaptive extended Kalman filter; ANFIS; adaptive neuro-fuzzy inference system; ANN; artificial neuronal networks; ASPKF; adaptive sigma-point Kalma
Keywords: AAPE; arachidonic acid (AA) induced paw edema model; ABTS; 2,2â²-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) assay; AIA; anti-inflammatory activity; AOTS; acute oral toxicity study; APE; adjuvant induced paw edema model; BKPE; Bradykinin induced pa
Keywords: ATDC; after top dead center; CAD; crank angle degree; EGR; exhaust gas recirculation; HC; hydrocarbons; NOx; oxides of nitrogen; PM; particulate matter; SOF; soluble organic fraction; ULSD; ultra low sulfur diesel fuel; EGR coolers; Fouling; Diesel engine
Keywords: AFT; adiabatic flame temperature; ANOVA; analysis of variance; BM (β); isentropic bulk modulus; c; speed of sound; CAD; crank angle degree; CN; cetane number; CO; carbon monoxide; CO2; carbon dioxide; COV; coefficient of variation; ELPI; electronic low p
Safety and Efficacy of Sofosbuvir and Daclatasvir for Hepatitis C Virus Infection in Patients with β-Thalassemia Major
Keywords: DAA; Direct Acting Antiviral; DCV; Daclatasvir; ETR; End of Treatment Response; HCV; Hepatitis C Virus; PegINF-α; Pegylated Interferon-α; RBV; Ribavirin; RVR; Rapid Virological Response; SOF; Sofosbuvir; SVR12; Sustained Virological Response Post-treatm
Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice
Keywords: HCV; Glecaprevir; Pibrentasvir; Sofosbuvir; NS5A inhibitor resistance associated variant; P32 deletion; Human hepatocyte chimeric mouse; ASV; asunaprevir; DAAs; Direct-acting antivirals; DCV; daclatasvir; GLE; glecaprevir; HCV; hepatitis C virus; LDV; led
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy
Keywords: Hepatitis C; Relapse; Direct-acting antivirals; Neutralizing antibodies; Sustained virological response; E1E2 envelope; HCV; hepatitis C virus; DAA; direct-acting antiviral; SVR; sustained virological response; RBV; ribavirin; PEG-IFN; pegylated-interfero
Development of a new approach of immunotherapy against scorpion envenoming: Avian IgYs an alternative to equine IgGs
Keywords: Aah; Androctonus australis hector; ED50; median effective dose; FCA; Freund's complete adjuvant; FIA; Freund's incomplete adjuvant; Fab; Fragment antigen binding; IgY; yolk immunoglobulin; IgG; Immunoglobulin G; LD50; median lethal dose; NMRI; Naval Medic
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis
Keywords: Direct-acting Antiviral; DAA; Short-duration; Pangenotypic; ALT; alanine aminotransferase; CI; confidence interval; DAA; direct-acting antiviral; G/P; glecaprevir/pibrentasvir; HCV; hepatitis C virus; IFN; interferon; ITT; intention-to-treat; LLOQ; lower
Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems
Keywords: HLCs; Antiviral; Primary Isolates; Personalized Medicine; ALB; albumin; AFP; alpha-fetoprotein; bFGF; basic fibroblast growth factor; BM; basal medium; CsA; cyclosporine A; DE; definitive endoderm; DMSO; dimethyl sulfoxide; Dox; doxycycline; ESC; embryoni
Impact of Direct Acting Antiviral Therapy for Treatment of Hepatitis C Genotypes 1, 3 and 4: A Real Life Experience from India
Keywords: DAA; Direct Acting Antiviral; DCV; Daclatasvir; EASL; European Association of Study of the Liver (EASL); ETR; End of Treatment Response; HBV; Hepatitis B; HCC; Hepatocellular Carcinoma; HCV; Hepatitis C Virus; HIV; Human Immunedeficiency Virus; ITT; inten
Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir
Keywords: POLARIS-1 and POLARIS-4; Fatigue; Work Productivity; Health Utility; Vitality; CLDQ-HCV; Chronic Liver Disease Questionnaire-HCV Version; DAAs; direct-acting antiviral agents; FACIT-F; Functional Assessment of Chronic Illness Therapy-Fatigue; HCV; hepatit
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals
Keywords: HCV; RASs; DAA; Virologic Treatment Failure; DAA; direct-acting antiviral; DCV; daclatasvir; EOT; end of treatment; GT; genotype; HCV; hepatitis C virus; LDV; ledipasvir; NS; nonstructural protein; PCR; polymerase chain reaction; PEG IFN; pegylated interf
The Mexican consensus on the treatment of hepatitis C
Keywords: Consensus; Direct-acting antiviral agents; Interferon-free regimens; Ribavirin; Consenso; Agentes antivirales de acción directa; RegÃmenes libres de interferón; Ribavirina; AASLD; American Association for the Study of Liver Diseases; AFP; alpha-fetopro
Oldest record of Mathildellidae (Crustacea: Decapoda: Goneplacoidea) associated with Retroplumidae from the Upper Cretaceous of NE Mexico
Keywords: Brachyura; Goneplacoidea; Mathildellidae; Retroplumidae; Late Cretaceous; Late Campanian; Mexico; a3-a6; abdominal somites; ant?; antenna?; as1-as4; anterolateral spines; cd; cardiac region; cdg; cardiac groove; cdt; tubercles of cardiac region; cg; cervi
Consenso Mexicano para el Tratamiento de la Hepatitis C
Keywords: Consenso; Agentes antivirales de acción directa; RegÃmenes libres de interferón; Ribavirina; Consensus; Direct-acting antiviral agents; Interferon-free regimens; Ribavirin; AAD; antivirales de acción directa; AASLD; Asociación Americana para el Estud
Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing
Keywords: Chronic hepatitis C; DAA treatment; Immune response; miRNA-122; HCV; hepatitis C virus; IP-10; interferon gamma-induced protein; CHC; chronic hepatitis C; DAAs; direct acting antivirals; SVR; sustained virological response; miR-122; microRNA-122; RAS; res
Effectiveness and Tolerability of Direct Acting Antiviral Therapy for Hepatitis C in a Real World Elderly Cohort
Keywords: DAA; direct acting antiviral; HCV; hepatitis C virus; LDV; ledipasvir; RBV; ribavirin; SMV; simeprevir; SOF; sofosbuvir; SVR12; sustained virologic response;
Deposit removal in EGR cooler and effectiveness improvement by non-thermal plasma reactor with different gas sources
Keywords: EGR; exhaust gas recirculation; NTP; non-thermal plasma; OES; optimal emission spectrometry; TGA; thermogravimetric analysis; LMTD; logarithmic mean temperature difference; PM; particulate matter; HC; hydrocarbon; SOF; soluble organic fraction; Gas source
An investigation on the particulate number and size distributions over the whole engine map from an optimized combustion strategy combining RCCI and dual-fuel diesel-gasoline
Keywords: Reactivity controlled compression ignition; Dual-fuel combustion; Dual-mode; EURO VI emissions; Efficiency; Engine map; AIM; Aerosol Instrument Manager; ASTM; American Society of Testing and Materials; ATDC; after top dead center; BDC; bottom dead center;
Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection
Keywords: Routine Clinical Practice; Direct-Acting Antiviral Agents; Cirrhosis; Genotype 4; DAA; direct-acting antiviral agent; EOT; end of treatment; GT; genotype; HCV; hepatitis C virus; LDV; ledipasvir; OMV; ombitasvir; PTV; paritaprevir; r; ritonavir; RBV; riba
Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis
Keywords: Antiviral Therapy; Direct-acting Antivirals; Liver Disease; Portal Hypertension; AUROC; areas under the receiver operating characteristic curve; CPT; Child-Pugh Turcotte; CPT-B; Child-Pugh Turcotte-stage B; CSPH; clinically significant portal hypertension
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis
Keywords: PRO; Quality of Life; Direct-Acting Antivirals; DAA; CLDQ-HCV; Chronic Liver Disease Questionnaire-HCV Version; CPT; Child-Pugh-Turcotte; FACIT-F; Functional Assessment of Chronic Illness Therapy-Fatigue; HCV; hepatitis C virus; PRO; patient-reported outc
Digital X-ray radiogrammetry in the study of osteoporotic fractures: Comparison to dual energy X-ray absorptiometry and FRAX
Keywords: AUC; area under curve; BMD; bone mineral density; DXA; dual energy X-ray absorptiometry; DXR; digital X-ray radiogrammetry; FN; femoral neck; MOF; major osteoporotic fracture; SD; standard deviation; SOF; the Study of Osteoporotic Fractures; VPA; volume p
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
Keywords: HCV; hepatitis C virus; DAA; direct-acting antiviral; MELD; model for end-stage liver disease; SVR; sustained virological response; EAP; expanded access programme; HCVRUK; hepatitis C Research UK; SOF; sofosbuvir; LDV; ledipasvir; DCV; daclatasvir; RBV; r
Research ArticlePharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C
Keywords: HCV; hepatitis C Virus; ESRD; end-stage renal disease; DAAs; direct-acting anti-HCV agents; SOF; sofosbuvir; LDV; ledipasvir; SOF-007TP; sofosbuvir uridine-triphosphate; SOF-007; predominant sofosbuvir inactive metabolite GS-331007; QD; once daily; TIW; t
Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension
Keywords: HVPG; hepatic venous pressure gradient; ACLD; advanced chronic liver disease; HCV; hepatitis C virus; PegIFN/RBV; pegylated interferon and ribavirin; SVR; sustained virologic response; IFN; interferon; SOF; sofosbuvir; TE; transient elastography; BL; base
Research ArticleClinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens
Keywords: SOF; sofosbuvir; CAP/CTM; COBAS AmpliPrep/COBAS TaqMan v2.0; ART; Abbott RealTime HCV test; GT; genotype; RBV; ribavirin; PegIFN; pegylated-interferon alfa; SMV; simeprevir; HCV; hepatitis C virus; SVR; sustained virological response; DAA; direct-acting a
NS5A resistance leading to failure of 24-week therapy with sofosbuvir/ledipasvir and ribavirin for the treatment of hepatitis C genotype 1a infection in a HIV-1 co-infected patient
Keywords: ALT; alanine aminotransferase; AST; aspartate aminotransferase; cART; combination antiretroviral therapy; DAA; direct-acting antiviral; DDI; drug-drug interaction; EOTR; end-of-treatment response; GT; genotype; HCV; hepatitis C virus; HIV-1; human immun
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin
Keywords: Antiviral; Chronic Hepatitis; Immunosuppression; Polymerase Inhibitor; gt; genotype; HCV; hepatitis C virus; HEV; hepatitis E virus; IC50; 50% inhibitory concentration; ORF; open reading frame; RBV; ribavirin; SOF; sofosbuvir;
Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections
Keywords: Clinical Trial; LEPTON; Difficult to Treat; Time of Treatment; DAA; direct-acting antiviral agent; HCV; hepatitis C virus; PEG+RBV; pegylated interferon plus ribavirin; RAS; resistance-associated substitution; SOF; sofosbuvir; SVR12; sustained virologic r
Usefulness of Extradural Optic Nerve Decompression via Trans-Superior Orbital Fissure Approach for Treatment of Traumatic Optic Nerve Injury: Surgical Procedures and Techniques from Experience with 8 Consecutive Patients
Keywords: Extradural optic canal decompression; Skull base; Surgical results; Traumatic optic neuropathy; ACP; Anterior clinoid process; CS; Cavernous sinus; CT; Computed tomography; EAC; Extradural anterior clinoidectomy; MOB; Meningo-orbital band; SOF; Superior o
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Keywords: HCV; hepatitis C virus; DAA; direct-acting antivirals; SVR; sustained virological response; MELD; model for end-stage liver disease; HCC; hepatocellular carcinoma; BCLC; Barcelona Clinic Liver Cancer group; LOD; limit of detection; EOT; end of treatment;
Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis
Keywords: Chronic Hepatitis C; Direct-Acting Antivirals; Decompensation; Safety; CI; confidence interval; CP; Child-Pugh; DAA; direct-acting antiviral; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HR; hazard ratio; MELD; model for end-stage liver diseas
Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response
Keywords: DAA; NS5A Inhibitor; NS5B Inhibitor; Antiviral; AE; adverse events; CI; confidence interval; HCV; hepatitis C virus; LDV; ledipasvir; OR; odds ratio; PPI; proton pump inhibitor; RBV; ribavirin; SOF; sofosbuvir; SVR; sustained virologic response; SVR12; su
Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient
Keywords: DAA; direct-acting antiviral agent; DAD; diffuse alveolar damage; FDA; Food and Drug Administration; HCV; hepatitis C virus; LT; liver transplant; SIM; simeprevir; SOF; sofosbuvir;
Clinical Trial Watch: Reports from the EASL International Liver Congress (ILC), Vienna, April 2015
Keywords: SOF; Sofosbuvir; DCV; Daclatasvir; RBV; Ribavirin; CP; Child-Pugh; SVR; Sustained virologial response; HVPG; Hepatic venous pressure gradient; G; Genotype; LDV; Ledipasvir; GZR; grazoprevir; EBR; Elbasvir; SMV; Simeprevir; CKD; Chronic kidney disease; RAV
Life Cycle Assessment of organic waste management strategies: an Italian case study
Keywords: Life Cycle Assessment; Organic waste; Landfill; Composting; Mechanical-biological treatment; ABF; aerobic biological facility; ATO; optimal territorial area; BT; biological treatment; CP; compost production; DM; dry matter; LF; landfilling; LCA; life cycl